Report Library
All ReportsDatamonitor Healthcare Oncology: Chronic Lymphocytic Leukemia (CLL) Disease Coverage
January 31, 2019
Chronic lymphocytic leukemia (CLL) is a disease characterized by an accumulation of mature malignant B lymphocytes in the peripheral
blood, bone marrow, and lymph nodes. Diagnosis of CLL is defined by an absolute B lymphocyte count of at least 5,000 cells per microliter for
three months. CLL represents the most common form of leukemia in Western countries, and predominantly affects older individuals; in the
US, the median age at diagnosis is 72 years.
This Datamonitor Healthcare Disease report contains Forecast, Treatment, Epidemiology, Marketed Drugs, and Pipeline modules.
This Datamonitor Healthcare Disease report contains Forecast, Treatment, Epidemiology, Marketed Drugs, and Pipeline modules.
Indications Covered: | Chronic Lymphocytic Leukemia (CLL)/Small Cell Lymphocytic Lymphoma (SLL) - NHL |